Vascular Biogenics Ltd (VBLT)

[tpizzazz24]

Is anyone optimistic that we could hear news tomorrow on the start of the a P3 Ovarian trial?
I read over last Q trqnscript and caught what the CEO was describing at the Nano deal and the Japan market..I also think from his description of the talks with FDA regarding the P3 Ovarian cancer study that the trial will also be getting a SPA from the FDA to follow on thr trial..hope we see another deal before the eoy..it's going to take between 6-10 months from the potential filing date of the BLA to receive a decision from the FDA regarding approval..hoping we dont have to go ahead with a secondary to help move things forward. Upfront 15M isnt that much considering the potential of VB 111. Hence the high teen % royalty on it when marketed.
A partner in China would be great IMO...Big market in China.
GLTA
BTW I finally pulled the trigger after weeks of sitting on my hands to open a position.
Sold off some EXEL to help finance that buy. Hope it was worth it. I think it just may be.
A 3000% rise on the MC would put us at 6B..that is a reasonable estimate being Roche brings that figure annually from Avastin sales. All we want to do is wet our beak..say 1B in sales a year in rGBN to start. We can worry about revenues in Ovarian, Thyroid and NSCLC later on.